PROVIDENCE – A California-based tech company has agreed to pay $9.8 million to resolve allegations it violated the False Claims Act for selling genomic-sequencing systems with critical security weaknesses to the federal government, acting U.S. Attorney for Rhode Island Sara Miron Bloom announced Thursday. The settlement reached in U.S. District Court in Rhode Island, resolves
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber














